Silver nanoparticles: Correlating nanoparticle size and cellular uptake with genotoxicity

Mutagenesis

Volumn 30, Issue 4, 2015, Pages 577-591

  Butler, Kimberly S ^a   Peeler, David J ^a   Casey, Brendan J ^a   Dair, Benita J ^a   Elespuru, Rosalie K ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SILVER NANOPARTICLE; SILVER NITRATE; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; MUTAGENIC AGENT; SILVER;

ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; FLOW CYTOMETRY; GENOTOXICITY; LEUKOCYTE; MAMMAL CELL; MEDICAL RESEARCH; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; OXIDATION; PARTICLE SIZE; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TRANSMISSION ELECTRON MICROSCOPY; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DNA REPAIR; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; JURKAT CELL LINE; METABOLISM; MICROBIOLOGY; MONOCYTE; MUTAGEN TESTING; PROCEDURES;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA; SALMONELLA TYPHIMURIUM;

ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; COMET ASSAY; DNA DAMAGE; DNA REPAIR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; JURKAT CELLS; METAL NANOPARTICLES; MICRONUCLEUS TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MONOCYTES; MUTAGENICITY TESTS; MUTAGENS; SALMONELLA TYPHIMURIUM; SILVER;

EID: 84936770490     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gev020     Document Type: Article

References (62)

1. Feng, Q. L., Wu, J., Chen, G. Q., Cui, F. Z., Kim, T. N. and Kim, J. O. (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res., 52, 662-668.
2. Kim, J. Y., Lee, C., Cho, M. and Yoon, J. (2008) Enhanced inactivation of E. coli and MS-2 phage by silver ions combined with UV-A and visible light irradiation. Water Res., 42, 356-362.
3. Ghandour, W., Hubbard, J. A., Deistung, J., Hughes, M. N. and Poole, R. K. (1988) The uptake of silver ions by Escherichia-coli-K12 -toxic effects and interaction with copper ions. Appl. Microbiol. Biotechnol., 28, 559-565.
4. Bragg, P. D. and Rainnie, D. J. (1974) The effect of silver ions on the respiratory chain of Escherichia coli. Can. J. Microbiol., 20, 883-889.
5. Slawson, R. M., Lohmeier-Vogel, E. M., Lee, H. and Trevors, J. T. (1994) Silver resistance in Pseudomonas stutzeri. Biometals, 7, 30-40.
6. Wells, T. N., Scully, P., Paravicini, G., Proudfoot, A. E. and Payton, M. A. (1995) Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine. Biochemistry, 34, 7896-7903.
7. Dibrov, P., Dzioba, J., Gosink, K. K. and Häse, C. C. (2002) Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae. Antimicrob. Agents Chemother., 46, 2668-2670.
8. Yakabe, Y., Sano, T., Ushio, H. and Yasunaga, T. (1980) Kinetic-studies of the interaction between silver ion and deoxyribonucleic-acid. Chem. Lett., 4, 373-376.
9. Choi, O. and Hu, Z. (2008) Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ. Sci. Technol., 42, 4583-4588.
10. Kim, S. and Ryu, D. Y. (2013) Silver nanoparticle-induced oxidative stress, genotoxicity and apoptosis in cultured cells and animal tissues. J. Appl. Toxicol., 33, 78-89.
11. Kim, Y. S., Song, M. Y., Park, J. D., et al. (2010) Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol., 7, 20.
12. Drake, P. L. and Hazelwood, K. J. (2005) Exposure-related health effects of silver and silver compounds: a review. Ann. Occup. Hyg., 49, 575-585.
13. Maillard, J. Y. and Hartemann, P. (2013) Silver as an antimicrobial: facts and gaps in knowledge. Crit. Rev. Microbiol., 39, 373-383.
14. Herrera, M., Carrin, P., Baca, P., Liébana, J. and Castillo, A. (2001) In vitro antibacterial activity of glass-ionomer cements. Microbios, 104, 141-148.
15. Bayston, R., Vera, L., Mills, A., Ashraf, W., Stevenson, O. and Howdle, S. M. (2010) In vitro antimicrobial activity of silver-processed catheters for neurosurgery. J. Antimicrob. Chemother., 65, 258-265.
16. Galiano, K., Pleifer, C., Engelhardt, K., Brssner, G., Lackner, P., Huck, C., Lass-Flrl, C. and Obwegeser, A. (2008) Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol. Res., 30, 285-287.
17. Roe, D., Karandikar, B., Bonn-Savage, N., Gibbins, B. and Roullet, J. B. (2008) Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J. Antimicrob. Chemother., 61, 869-876.
18. Samuel, U. and Guggenbichler, J. P. (2004) Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents, 23, S75-S78.
19. Stevens, K. N., Croes, S., Boersma, R. S., Stobberingh, E. E., van der Marel, C., van der Veen, F. H., Knetsch, M. L. and Koole, L. H. (2011) Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters. Biomaterials, 32, 1264-1269.
20. Kostenko, V., Lyczak, J., Turner, K. and Martinuzzi, R. J. (2010) Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob. Agents Chemother., 54, 5120-5131.
21. Li, Y., Leung, P., Yao, L., Song, Q. W. and Newton, E. (2006) Antimicrobial effect of surgical masks coated with nanoparticles. J. Hosp. Infect., 62, 58-63.
22. Carlson, C., Hussain, S. M., Schrand, A. M., Braydich-Stolle, L. K., Hess, K. L., Jones, R. L. and Schlager, J. J. (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B, 112, 1360813619.
23. Sotiriou, G. A. and Pratsinis, S. E. (2010) Antibacterial activity of nanosilver ions and particles. Environ. Sci. Technol., 44, 5649-5654.
24. Xiu, Z. M., Zhang, Q. B., Puppala, H. L., Colvin, V. L. and Alvarez, P. J. (2012) Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett., 12, 4271-4275.
25. Pal, S., Tak, Y. K. and Song, J. M. (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol., 73, 1712-1720.
26. Yang, X., Gondikas, A. P., Marinakos, S. M., Auffan, M., Liu, J., Hsu-Kim, H. and Meyer, J. N. (2012) Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans. Environ. Sci. Technol., 46, 1119-1127.
27. Ma, R., Levard, C., Marinakos, S. M., Cheng, Y., Liu, J., Michel, F. M., Brown, G. E. and Lowry, G. V. (2012) Size-controlled dissolution of organic-coated silver nanoparticles. Environ. Sci. Technol., 46, 752-759.
28. Sharma, V. K., Siskova, K. M., Zboril, R. and Gardea-Torresdey, J. L. (2014) Organic-coated silver nanoparticles in biological and environmental conditions: fate, stability and toxicity. Adv. Colloid Interface Sci., 204, 15-34.
29. Zhang, T., Wang, L., Chen, Q. and Chen, C. (2014) Cytotoxic potential of silver nanoparticles. Yonsei Med. J., 55, 283-291.
30. Gliga, A. R., Skoglund, S., Wallinder, I. O., Fadeel, B. and Karlsson, H. L. (2014) Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part. Fibre Toxicol., 11, 11.
31. Park, M. V., Neigh, A. M., Vermeulen, J. P., de la Fonteyne, L. J., Verharen, H. W., Briedé, J. J., van Loveren, H. and de Jong, W. H. (2011) The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials, 32, 9810-9817.
32. Ahamed, M., Karns, M., Goodson, M., Rowe, J., Hussain, S. M., Schlager, J. J. and Hong, Y. (2008) DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol., 233, 404-410.
33. Sur, I., Altunbek, M., Kahraman, M. and Culha, M. (2012) The influence of the surface chemistry of silver nanoparticles on cell death. Nanotechnology, 23, 375102.
34. Kim, J. S., Sung, J. H., Ji, J. H., Song, K. S., Lee, J. H., Kang, C. S. and Yu, I. J. (2011) In vivo Genotoxicity of Silver Nanoparticles after 90-day Silver Nanoparticle Inhalation Exposure. Saf. Health Work, 2, 34-38.
35. Sung, J. H., Ji, J. H., Park, J. D., et al. (2009) Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci., 108, 452-461.
36. AshaRani, P. V., Low Kah Mun, G., Hande, M. P. and Valiyaveettil, S. (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano, 3, 279-290.
37. Sahu, S. C., Zheng, J., Graham, L., Chen, L., Ihrie, J., Yourick, J. J. and Sprando, R. L. (2014) Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J. Appl. Toxicol., 34, 1155-1166.
38. Greulich, C., Diendorf, J., Gessmann, J., Simon, T., Habijan, T., Eggeler, G., Schildhauer, T. A., Epple, M. and Kller, M. (2011) Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater., 7, 3505-3514.
39. Maron, D. M. and Ames, B. N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
40. Doak, S. H., Manshian, B., Jenkins, G. J. and Singh, N. (2012) In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat. Res., 745, 104-111.
41. Warheit, D. B. and Donner, E. M. (2010) Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Nanotoxicology, 4, 409-413.
42. Doak, S. H., Manshian, B., Jenkins, G. J. and Singh, N. (2012) In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat. Res., 745, 104-111.
43. Landsiedel, R., Kapp, M. D., Schulz, M., Wiench, K. and Oesch, F. (2009) Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations-many questions, some answers. Mutat. Res., 681, 241-258.
44. Donaldson, K., Poland, C. A. and Schins, R. P. (2010) Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies. Nanotoxicology, 4, 414-420.
45. Kim, H. R., Park, Y. J., Shin, d. a. Y., Oh, S. M. and Chung, K. H. (2013) Appropriate in vitro methods for genotoxicity testing of silver nanoparticles. Environ. Health Toxicol., 28, e2013003.
46. Li, Y., Chen, D. H., Yan, J., Chen, Y., Mittelstaedt, R. A., Zhang, Y., Biris, A. S., Heflich, R. H. and Chen, T. (2012) Genotoxicity of silver nanoparticles evaluated using the Ames test and in vitro micronucleus assay. Mutat. Res., 745, 4-10.
47. Mei, N., Zhang, Y., Chen, Y., et al. (2012) Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ. Mol. Mutagen., 53, 409-419.
48. Kim, Y. J., Sung, I. Y. and Ryu, J. C. (2010) Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines. Mol. Cell. Toxicol., 6, 119-125.
49. Jiang, X., Foldbjerg, R., Miclaus, T., et al. (2013) Multi-platform genotoxicity analysis of silver nanoparticles in the model cell line CHO-K1. Toxicol. Lett., 222, 55-63.
50. Kim, H. R., Kim, M. J., Lee, S. Y., Oh, S. M. and Chung, K. H. (2011) Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat. Res., 726, 129-135.
51. van der Zande, M., Vandebriel, R. J., Van Doren, E., et al. (2012) Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano, 6, 7427-7442.
52. Beer, C., Foldbjerg, R., Hayashi, Y., Sutherland, D. S. and Autrup, H. (2012) Toxicity of silver nanoparticles -nanoparticle or silver ion? Toxicol. Lett., 208, 286-292.
53. Kang, S. J., Ryoo, I. G., Lee, Y. J. and Kwak, M. K. (2012) Role of the Nrf2-heme oxygenase-1 pathway in silver nanoparticle-mediated cytotoxicity. Toxicol. Appl. Pharmacol., 258, 89-98.
54. Nymark, P., Catalán, J., Suhonen, S., et al. (2013) Genotoxicity of polyvinylpyrrolidone-coated silver nanoparticles in BEAS 2B cells. Toxicology, 313, 38-48.
55. Foldbjerg, R., Dang, D. A. and Autrup, H. (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch. Toxicol., 85, 743-750.
56. Ghosh, M., J, M., Sinha, S., Chakraborty, A., Mallick, S. K., Bandyopadhyay, M. and Mukherjee, A. (2012) In vitro and in vivo genotoxicity of silver nanoparticles. Mutat. Res., 749, 60-69.
57. Lim, H. K., Asharani, P. V. and Hande, M. P. (2012) Enhanced genotoxicity of silver nanoparticles in DNA repair deficient Mammalian cells. Front. Genet., 3, 104.
58. Flower, N. A., Brabu, B., Revathy, M., Gopalakrishnan, C., Raja, S. V., Murugan, S. S. and Kumaravel, T. S. (2012) Characterization of synthesized silver nanoparticles and assessment of its genotoxicity potentials using the alkaline comet assay. Mutat. Res., 742, 61-65.
59. Butler, K. S., Casey, B. J., Garborcauskas, G. V., Dair, B. J. and Elespuru, R. K. (2014) Assessment of titanium dioxide nanoparticle effects in bacteria: association, uptake, mutagenicity, co-mutagenicity and DNA repair inhibition. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 768, 14-22.
60. Kim, Y. J., Yang, S. I. and Ryu, J. C. (2010) Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines. Mol. Cell. Toxicol., 6, 119-125.
61. Mei, N., Zhang, Y., Chen, Y., et al. (2012) Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ. Mol. Mutagen., 53, 409-419.
62. Dair, B. J., Saylor, D. M., Cargal, T. E., et al. (2010) The effect of substrate material on silver nanoparticle antimicrobial efficacy. J. Nanosci. Nanotechnol., 10, 8456-8462.